SOUTH KOREA · OPENDART
BioPlus Co., Ltd
바이오플러스 · 099430 · KOSDAQ · Healthcare · Medical Instruments & Supplies
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 5,094.03 KRW a share on average (7 purchase lines, 2 buyers, 2026-01-21 – 2026-02-02). The close on 2026-10-16 was 29.7% below that price.
The latest purchase (2026-02-02) was at 5,240.00 KRW; the close was 31.7% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-02 | Han In-seok | Vice chairman | Bought on the exchange | 1,900 | ₩5,240 | ₩10.0M | DART ↗ |
| 2026-01-30 | Han In-seok | Vice chairman | Bought on the exchange | 3,600 | ₩5,500 | ₩19.8M | DART ↗ |
| 2026-01-26 | Han In-seok | Vice chairman | Bought on the exchange | 900 | ₩5,300 | ₩4.8M | DART ↗ |
| 2026-01-23 | JUNG HYUN KYU | CEO | Bought on the exchange | 114,384 | ₩5,195 | ₩594.2M | DART ↗ |
| 2026-01-22 | Han In-seok | Vice chairman | Bought on the exchange | 1,800 | ₩5,500 | ₩9.9M | DART ↗ |
| 2026-01-22 | JUNG HYUN KYU | CEO | Bought on the exchange | 82,449 | ₩5,074 | ₩418.3M | DART ↗ |
| 2026-01-21 | JUNG HYUN KYU | CEO | Bought on the exchange | 133,500 | ₩5,000 | ₩667.5M | DART ↗ |